GlassScriptPhysician profile
Brendan B Mitchell
NPI 1356346175
$6,685.00
in general payments reported to CMS, 2019-2025
32 companies · $582 in 2025
The $582 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,673 · 2020: $242 · 2021: $743 · 2022: $1,069 · 2023: $808 · 2024: $568 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,958.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $2,329.46 | 2019-2023 | |
| Abbvie INC. | $842.38 | 2019-2024 | |
| Biogen, INC. | $376.17 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $352.44 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $300.39 | 2023-2025 | Myfembree |
| Pfizer INC. | $287.13 | 2021-2024 | |
| Daiichi Sankyo INC. | $278.75 | 2019-2023 | Injectafer |
| Mayne Pharma Commercial LLC | $237.86 | 2023-2025 | |
| Gynesonics, INC. | $212.17 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $198.57 | 2019-2022 | |
| Depuy Synthes Sales INC. | $135.15 | 2023 | Na |
| Bayer Healthcare Pharmaceuticals INC. | $115.95 | 2019-2025 | |
| Coopersurgical, INC. | $113.48 | 2021-2024 | Paragard T 380a |
| Organon LLC | $113.38 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $98.67 | 2020-2025 | Veozah |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $77.16 | 2025 | Intrarosa, Femring, Femlyv |
| Exeltis, USA INC. | $74.27 | 2021-2025 | Slynd |
| Aspira Women'S Health INC | $69.98 | 2022 | |
| Stryker Corporation | $65.29 | 2023 | Mako |
| Hologic Sales and Service, LLC | $55.55 | 2022-2024 | Aptima, Third Wave, Thinprep 2000 Processor |
| Agile Therapeutics, INC. | $54.43 | 2021-2022 | |
| Avion Pharmaceuticals | $52.86 | 2021-2022 | |
| Teleflex LLC | $43.07 | 2025 | Quikclot |
| Shield Therapeutics INC | $34.17 | 2025 | |
| Amag Pharmaceuticals, INC. | $32.19 | 2019 | |
| Covidien LP | $30.44 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $21.57 | 2025 | Exparel |
| Monaghan Medical Corporation | $20.81 | 2023 | Aeroeclipse |
| Biocomposites INC | $17.54 | 2024 | |
| Olympus America INC. | $17.11 | 2021 | |
| Evofem Biosciences, INC. | $13.41 | 2021 | |
| Intuitive Surgical, INC. | $13.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brendan Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.